Eric Dube

Eric Dube

Chief Executive Officer at TRAVERE THERAPEUTICS, INC.

Net worth: 20 M $ as of 2026-05-30

53 year
Health Technology
Commercial Services
Consumer Services

Profile

Eric M.
Dube
is President, Chief Executive Officer & Director at Travere Therapeutics, Inc. since 2019.
Dr. Dube is Director at Biotechnology Innovation Organization.
Former roles include Director at Biocom, Inc. and Independent Director at Reneo Pharmaceuticals, Inc. Dr. Dube was SVP & Head-Global Respiratory Franchise at GSK Plc from 2015 to 2017.
Dr. Dube was President & Head-North America at ViiV Healthcare Ltd. in 2018.
Dr. Dube was Trustee at Aids United and Biocom California.
Dr. Dube was Senior VP & Head-Global Respiratory Franchise at GlaxoSmithKline KK from 2015 to 2017.
Education includes graduate and doctorate degrees from Cornell University and an undergraduate degree from Santa Clara University conferred in 1994.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-05 432,886 ( 0.47% ) 20 M $ 2026-05-30

Eric Dube active positions

CompaniesPositionStart
TRAVERE THERAPEUTICS, INC. Chief Executive Officer 2019-01-03
Director/Board Member -

Former positions of Eric Dube

CompaniesPositionEnd
President 2018-11-30
GSK PLC Corporate Officer/Principal 2017-11-30
Corporate Officer/Principal 2017-11-30
ONKURE THERAPEUTICS, INC. Director/Board Member -
See the detail of Eric Dube's experience

Training of Eric Dube

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

66

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Consumer Non-Durables

Commercial Services

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!